Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ingmar Bruns currently holds 43,059 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ingmar Bruns has been a net seller of ZNTL stock. They have purchased $0 and sold $8.0K worth of shares.
Ingmar Bruns's most recent insider trade was on Sep 30, 2026, when they sold 9,727 shares at $2.18 per share.
Ingmar Bruns serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 5 insider transactions totaling $8.0K over their tenure at the company.
Ingmar Bruns holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Ingmar Bruns has shown a selling trading pattern, with $0 in total purchases and $8.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ingmar Bruns was on Sep 30, 2026, when they purchased $21.2K worth of ZNTL shares. This transaction involved 9,727 shares at $2.18 per share.
Ingmar Bruns currently owns 43,059 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ingmar Bruns's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ingmar Bruns has 5 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for Ingmar Bruns and 40,000+ other insiders.